Posts by Magali Bischof

Aktiia raises new funds to finalise last steps towards market entry   Neuchâtel-based Aktiia, created in 2018, has developed a cuffless blood monitoring device, based on 15 years of research, which uses standard optical sensors. The device and analytics methodology were validated through clinical trials which took place at the Lausanne University Hospital. On 24…

European Commission seeks to delay the new EU Medical Devices Regulation (MDR)   Stella Kyriakides, the European Commissioner for Health and Food Safety, will propose a delay of one year for the new MDR, initially due to be implemented on 26 May 2020.   Due to the current situation linked to the spread of COVID-19,…

Swiss Medtech companies defined as part of Switzerland’s critical infrastructure   The Federal Department of Defence, Civil Protection and Sport (DDPS) issued a letter to Swiss Medtech confirming that the association and its member companies are part of Switzerland’s critical infrastructure. The Swiss medtech industry is essential in providing services for the population’s health, in…

Rheon Medical to launch its eyeWatch product on the Swiss and EU markets   The Vaud-based startup, Rheon Medical, specialised in non-invasive surgical treatments for glaucoma, has acquired the CE Marking for its eyeWatchTM product. This ocular implant enables an efficient control of intraocular pressure thanks to its unique technology and external control device.  …

1Drop brings medical diagnostics to space   The Neuchâtel-based company, 1Drop Diagnostics, which specialises in the detection of cardiovascular biomarkers using a single drop of blood, joins forces with the International Space Station National Lab.   Through this collaboration on lab-on-a-chip technology for medical diagnostics, 1Drop will contribute to the first capillary-driven microfluids experiment in…

Teams from UNIFR & SICHH discover a new Alzheimer diagnosis solution based on saliva analysis   The University of Fribourg (UNIFR), the Swiss Integrative Center for Human Health (SICHH) and the Fribourg Cantonal Hospital (HFR) discovered a new method of identifying early stage Alzheimer’s disease.   The disease develops over the course of 10 years, many…

Abionic’s R&D focuses on the development of an early sepsis diagnosis solution | A tool for Coronavirus identification   Abionic, based at the Biopole in Lausanne, has developed an innovative solution enabling the diagnosis of sepsis within 5 minutes through the use of a single drop of blood.   Sepsis is also one of the…

Abionic to commercialise its rapid sepsis diagnosis product on the EU and US markets   The Abionic team, who has now reached over 50 members at the Biopôle in Epalinges, starts this new decade with a successful outlook.   After raising 20 million Swiss francs in 2018, enabling a succession of successful clinical trials in…

BioAlps Networking Day 2019 | Discover key speaker interviews by GGBa   The Greater Geneva Bern area (GGBa) collaborated with BioAlps once again to produce the BioAlps Networking Day 2019 video. Discover our speakers’ views on western Switzerland’s innovation potential and the advantages of being a life sciences company in the region.     Video speakers Mr…

NeuroRestore Center | A new partnership to restore neurological functions through research, innovation and treatment   Defitech Foundation is partnering with the EPFL, CHUV and UNIL to extend the research and identify innovative treatment solutions for patients who have suffered from a stroke or have been diagnosed with Parkinson’s disease. Following the great achievements of the…